Crowdonomics
All companies

Adia Nutrition, Inc.

Public

Biotech · Winter Park, FL

Estimated pre-money ⓘ
$1.2M
As of Apr 2024 · from Reg A Offering (2024) · our estimate: offering price × shares outstanding, not a stated valuation
Total raised
$0
Across 1 round since 2024
Latest share price
$0.0125
Reg A Offering (2024) offering price

Financials

FY2023–FY2025 · from SEC filings · hover any figure for its source
$0
−$750
2023
$6K
−$181K
2024
$701K
−$395K
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2023 unaudited
FY2024 audited
FY2025 audited
Income statement
Revenue
$0
$6,380
$700,508
Cost of goods sold
$0
$4,186
$508,838
Gross margin
—
34%
27%
Net income
-$750
-$181,067
-$395,464
Taxes paid
—
$0
$0
Balance sheet
Cash
$500
$6,323
$79,392
Accounts receivable
$0
$0
$33,360
Total assets
$500
$666,181
$594,826
Long-term debt
$0
—
—
Total liabilities
$1,250
$640,641
$852,500
Other
Headcount
2
—
—

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$1.2M
est. pre-money
Reg A+ · Equity · Apr 2024

Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Cap table

Share counts as of Jun 30, 2026
Series C Preferred Stock · 6.9%Class A Common Stock · 93.1%
ClassOutstandingVotes / shareConvertsAs convertedLast price
Series C Preferred Stockpreferred1,750,00014 × Class A Common Stock6.9%—
Class A Common Stock94,404,696——93.1%—
Total96,154,696101,404,696 as converted100%

Shares outstanding over timein today's share terms

106M53M0
Apr 2024Dec 2025
Class A Common StockCommon StockSeries A Preferred StockSeries C Preferred Stock

Principal holders% as the filing states it, Mar 31, 2026

  • Legends Investment Properties1 Special 2022 Series A Preferred Stock100.0%of Special 2022 Series A Preferred
  • Legends Investment Properties10,000,000 Series C Preferred Stock50.9%of Series C Preferred
  • Rebecca Miller5,000,000 Series C Preferred Stock25.5%of Series C Preferred
  • Cement Factory1,875,000 Series C Preferred Stock9.6%of Series C Preferred
  • Kalpesh Barot, MD250,000 Series C Preferred Stock1.3%of Series C Preferred
  • Monica Sher, MD250,000 Series C Preferred Stock1.3%of Series C Preferred
  • Evan Thomas, MD, Ph.D.250,000 Series C Preferred Stock1.3%of Series C Preferred
  • Richard Edwards, DO250,000 Series C Preferred Stock1.3%of Series C Preferred

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. “As converted” counts each class in the shares it converts into. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $0 / $937.5KEst. pre-money $1.2M

Team

2 people
Larry Powalisz
Chief Executive Officer, President, Secretary and Director
Rebecca Miller
Chief Financial Officer

Names and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.

  • Form 10-QAug 13, 20260001683168-26-006313
    EDGAR
  • Form 10-QMay 15, 20260001683168-26-003957
    EDGAR
  • Form 10-KMar 31, 20260001683168-26-002531
    EDGAR
  • Form 253G1Jun 24, 20240001683168-24-004436
    EDGAR
  • Form QUALIFJun 21, 20249999999994-24-000088
    EDGAR
  • Form 1-A/AJun 18, 20240001683168-24-004292
    EDGAR
  • Form 1-A/AJun 10, 20240001683168-24-004080
    EDGAR
  • Form 1-A/AMay 24, 20240001683168-24-003815
    EDGAR
Source: SEC EDGARCIK 0001160420NVShare price $0.0125Last synced Aug 16, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.